| EP3125904 - AUTOIMMUNITY AND MULTIPLE SCLEROSIS TREATMENT [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 08.06.2018 Database last updated on 30.03.2026 | |
| Former | Request for examination was made Status updated on 06.01.2017 | ||
| Former | The international publication has been made Status updated on 31.10.2016 | Most recent event Tooltip | 27.02.2026 | New entry: Date of oral proceedings | Applicant(s) | For all designated states University of Southern California 1150 South Olive Street, Suite 2300 Los Angeles, CA 90015 / US | [2017/06] | Inventor(s) | 01 /
LONGO, Valter D. 8240 Zitola Terrace Playa del Rey, California 90293 / US | 02 /
CHOI, In Young 9761 Royal Palm Boulevard Garden Grove, California 92841 / US | [2017/06] | Representative(s) | GPI Brevets 1330, rue Guillibert de la Lauzière EuroParc de Pichaury Bât B2 13856 Aix en Provence Cedex 3 / FR | [N/P] |
| Former [2017/06] | GPI & Associés EuroParc de Pichaury Bâtiment B2 - 1er Etage 1330, rue Guillibert de la Lauzière 13856 Aix-en-Provence Cedex 3 / FR | Application number, filing date | 15774032.5 | 02.04.2015 | [2017/06] | WO2015US24021 | Priority number, date | US201461974189P | 02.04.2014 Original published format: US 201461974189 P | [2017/06] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2015153850 | Date: | 08.10.2015 | Language: | EN | [2015/40] | Type: | A2 Application without search report | No.: | EP3125904 | Date: | 08.02.2017 | Language: | EN | The application published by WIPO in one of the EPO official languages on 08.10.2015 takes the place of the publication of the European patent application. | [2017/06] | Search report(s) | International search report - published on: | KR | 08.10.2015 | (Supplementary) European search report - dispatched on: | EP | 31.07.2017 | Classification | IPC: | A61K31/70, A61K38/00, A61P29/00 | [2017/06] | CPC: |
A23L33/30 (EP,KR,US);
A61K31/70 (KR,RU);
A61K38/00 (EP,KR,US);
A61K45/06 (EP,KR,US);
A61P21/00 (EP);
A61P25/00 (EP);
A61P25/02 (EP);
A61P25/18 (EP);
A61P25/24 (EP);
A61P25/28 (EP);
A61P27/02 (EP);
A61P29/00 (EP);
A61P37/02 (EP);
A61P37/06 (EP);
G01N33/564 (US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2017/06] | Title | German: | BEHANDLUNG VON AUTOIMMUNITÄT UND MULTIPLER SKLEROSE | [2017/06] | English: | AUTOIMMUNITY AND MULTIPLE SCLEROSIS TREATMENT | [2017/06] | French: | TRAITEMENT DE L'AUTO-IMMUNITÉ ET DE LA SCLÉROSE EN PLAQUES | [2017/06] | Entry into regional phase | 31.10.2016 | National basic fee paid | 31.10.2016 | Search fee paid | 31.10.2016 | Designation fee(s) paid | 31.10.2016 | Examination fee paid | Examination procedure | 31.10.2016 | Examination requested [2017/06] | 31.10.2016 | Date on which the examining division has become responsible | 17.01.2018 | Amendment by applicant (claims and/or description) | 07.06.2018 | Despatch of a communication from the examining division (Time limit: M04) | 09.08.2018 | Reply to a communication from the examining division | 17.03.2022 | Despatch of a communication from the examining division (Time limit: M04) | 07.07.2022 | Reply to a communication from the examining division | 30.10.2023 | Despatch of a communication from the examining division (Time limit: M04) | 20.02.2024 | Reply to a communication from the examining division | 02.12.2026 | Date of oral proceedings | Fees paid | Renewal fee | 27.04.2017 | Renewal fee patent year 03 | 27.04.2018 | Renewal fee patent year 04 | 29.04.2019 | Renewal fee patent year 05 | 27.04.2020 | Renewal fee patent year 06 | 27.04.2021 | Renewal fee patent year 07 | 27.04.2022 | Renewal fee patent year 08 | 27.04.2023 | Renewal fee patent year 09 | 29.04.2024 | Renewal fee patent year 10 | 28.04.2025 | Renewal fee patent year 11 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [I] WO2006118665 (ACCERA INC et al.) [I] 1-15 * page 5, lines 2-20; page 7, lines 5-24; page 9, lines 7-16; page 1, lines 7-11; example 1; claims 1-20 * | [I] WO2013028555 (EUROP KETOGENIC WEIGHT LOSS CLINICS LLC et al.) [I] 1-15 * paragraph 34; claims 1-22 * | [A] EP2353595 (MEAD JOHNSON NUTRITION CO et al.) [A] 1-15 * claims 1-15 * | Examination | OF ET AL: "DIETARY GUIDELINES FOR AMERICANS 2015-2020 (EIGHTH EDITION)", ROOM 509F HHH BLDG, 1 December 2015 (2015-12-01), XP055900502, Retrieved from the Internet |